Lowe, S H <br/><br/>
Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES).  [electronic resource] 

 -  HIV clinical trials   
 - 235-45 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-4336 
<br/><br/><label>Standard No.: </label>10.1310/A686-M37Y-J2PT-E9GJ  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--administration & dosage<br/>Antiretroviral Therapy, Highly Active<br/>CD4 Lymphocyte Count<br/>Didanosine--administration & dosage<br/>Female<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--administration & dosage<br/>HIV-1--drug effects<br/>Humans<br/>Lamivudine--administration & dosage<br/>Male<br/>Nelfinavir--administration & dosage<br/>Nevirapine--administration & dosage<br/>RNA, Viral--blood<br/>Reverse Transcriptase Inhibitors--administration & dosage<br/>Ritonavir--administration & dosage<br/>Saquinavir--administration & dosage<br/>Stavudine--administration & dosage<br/>Viral Load